Common Shares Outstanding: The number of class A shares currently held by investors.
Silence Therapeutics PLC Sponsored ADR (SLN) had Common Shares Outstanding of 47.23M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.03M |
|
$-11.77M |
|
$0.01M |
|
$0.02M |
|
$12.49M |
|
$-12.46M |
|
$0.69M |
|
$-11.77M |
|
$-11.77M |
|
$-11.77M |
|
$-11.77M |
|
$-11.77M |
|
$-11.77M |
|
$-12.46M |
|
$-12.35M |
|
47.23M |
|
47.23M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$118.66M |
|
$1.58M |
|
$12.78M |
|
$131.44M |
|
$13.61M |
|
-- |
|
$55.52M |
|
$69.14M |
|
$62.30M |
|
$51.40M |
|
$62.30M |
|
|
Common Shares Outstanding |
47.23M |
| Cash Flow Statement Financials | |
$-62.27M |
|
$-47.99M |
|
$0.01M |
|
$121.33M |
|
$11.28M |
|
$-110.05M |
|
$8.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
64.71% |
|
-36649.96% |
|
-36649.96% |
|
-- |
|
-34617.61% |
|
-34617.62% |
|
$-62.33M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.00 |
|
-- |
|
-18.89% |
|
-22.90% |
|
-8.95% |
|
-18.89% |
|
$1.32 |
|
$-1.32 |
|
$-1.32 |
|